Completed

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

NCT03892096

What is this trial?

Generating plain-language summary...

Generating eligibility summary...

Summarizing study design...

Primary location

CARTI Cancer Center

Little Rock, Arkansas, United States

+11 additional locations

Save this trial

CARTI Cancer CenterLittle Rock, Arkansas, United States
Sutter Health - Palo Alto Medical FoundationSunnyvale, California, United States
Rocky Mountain Cancer CentersDenver, Colorado, United States
IACT HealthColumbus, Georgia, United States
University Medical CenterNew Orleans, Louisiana, United States
Southeast Louisiana Veterans Health Care SystemNew Orleans, Louisiana, United States
Nebraska Cancer CenterOmaha, Nebraska, United States
National Translational Research Group LLCPort Jefferson Station, New York, United States
Waverly Hematology OncologyCary, North Carolina, United States
Advent HealthHendersonville, North Carolina, United States
Greenville Health System - Prisma HealthGreenville, South Carolina, United States
McGill UniversityMontreal, Quebec, Canada